Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$40.29 - $82.51 $118,492 - $242,661
-2,941 Reduced 11.39%
22,880 $949,000
Q1 2023

Jan 10, 2025

BUY
$56.44 - $118.81 $35,500 - $74,731
629 Added 2.5%
25,821 $1.55 Million
Q1 2023

May 11, 2023

BUY
$56.44 - $118.81 $35,500 - $74,731
629 Added 2.5%
25,821 $1.55 Million
Q4 2022

Jan 10, 2025

BUY
$63.98 - $85.37 $176,200 - $235,108
2,754 Added 12.27%
25,192 $1.85 Million
Q4 2022

Feb 14, 2023

BUY
$63.98 - $85.37 $176,200 - $235,108
2,754 Added 12.27%
25,192 $1.85 Million
Q3 2022

Jan 10, 2025

BUY
$67.99 - $89.57 $165,759 - $218,371
2,438 Added 12.19%
22,438 $1.7 Million
Q3 2022

Nov 10, 2022

BUY
$67.99 - $89.57 $165,759 - $218,371
2,438 Added 12.19%
22,438 $1.71 Million
Q2 2022

Jan 10, 2025

BUY
$56.6 - $89.9 $135,840 - $215,760
2,400 Added 13.64%
20,000 $1.39 Million
Q2 2022

Aug 12, 2022

BUY
$56.6 - $89.9 $135,840 - $215,760
2,400 Added 13.64%
20,000 $1.39 Million
Q1 2022

Jan 10, 2025

BUY
$60.15 - $84.52 $1.06 Million - $1.49 Million
17,600 New
17,600 $1.46 Million
Q3 2021

Jan 10, 2025

BUY
$116.17 - $194.55 $139,404 - $233,460
1,200 Added 7.32%
17,600 $2.04 Million
Q3 2021

Nov 12, 2021

BUY
$116.17 - $194.55 $139,404 - $233,460
1,200 Added 7.32%
17,600 $2.05 Million
Q2 2021

Jan 10, 2025

BUY
$130.4 - $225.58 $156,480 - $270,696
1,200 Added 7.89%
16,400 $3.64 Million
Q2 2021

Aug 06, 2021

BUY
$130.4 - $225.58 $156,480 - $270,696
1,200 Added 7.89%
16,400 $3.64 Million
Q1 2021

Jan 10, 2025

BUY
$124.11 - $190.17 $1.89 Million - $2.89 Million
15,200 New
15,200 $2.01 Million
Q1 2021

May 14, 2021

BUY
$124.11 - $190.17 $27,304 - $41,837
220 Added 1.47%
15,200 $2.01 Million
Q4 2020

Jan 10, 2025

BUY
$112.16 - $174.14 $1.68 Million - $2.61 Million
14,980 New
14,980 $2.59 Million
Q4 2020

Feb 12, 2021

BUY
$112.16 - $174.14 $1.68 Million - $2.61 Million
14,980 New
14,980 $2.59 Million

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $2.88B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Nomura Asset Management CO LTD Portfolio

Follow Nomura Asset Management CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Asset Management CO LTD with notifications on news.